share_log

Arcutis Biotherapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  May 2 15:34
Summary by Moomoo AI
Arcutis Biotherapeutics, Inc. officer Matthew Richard Moore is set to sell 4,681 shares of common stock on 05/02/2024, according to a recent filing. The shares, valued at an aggregate market price of $40,901, were acquired through a restricted stock vest on 05/01/2024. This transaction follows a previous sale of 3,468 shares in the past three months, which had gross proceeds of $38,568.
Arcutis Biotherapeutics, Inc. officer Matthew Richard Moore is set to sell 4,681 shares of common stock on 05/02/2024, according to a recent filing. The shares, valued at an aggregate market price of $40,901, were acquired through a restricted stock vest on 05/01/2024. This transaction follows a previous sale of 3,468 shares in the past three months, which had gross proceeds of $38,568.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more